Transcription of Guideline on Active Substance Master File Procedure
{{id}} {{{paragraph}}}
Example: biology
Guideline on Active Substance Master File Procedure
31 May 2013 Committee of Human Medicinal Products CHMP/QWP/227/02 Rev 3/Corr * Committee of Veterinary Medicinal Products EMEA/CVMP/134/02 Rev 3/Corr * Guideline on Active Substance Master File Procedure Final Discussion at the HMPC November 2005 January 2006 Adoption by the HMPC 22 January 2006 Draft agreed by Quality Working Party 9 February 2006 Adoption by CHMP for release for consultation 23 March 2006 Adoption by CVMP for release for consultation 20 April 2006 End of consultation (deadline for comments) 30 August 2006 Agreed by Quality Working Party 1 December 2011 Adoption by CHMP for release for consultation 15 December 2011 Adoption by CVMP for release for consultation 12 January 2012 End of consultation (deadline for comments) 12 March 2012 Rev.
31 May 2013. Committee of Human Medicinal Products CHMP/QWP/227/02 Rev 3/Corr * Committee of Veterinary Medicinal Products EMEA/CVMP/134/02 Rev 3/Corr *
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: